| Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial W Tang, Z Cao, M Han, Z Wang, J Chen, W Sun, Y Wu, W Xiao, S Liu, ... bmj 369, 2020 | 1304 | 2020 |
| Global multi-stakeholder endorsement of the MAFLD definition N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ... The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022 | 214 | 2022 |
| VV116 versus nirmatrelvir–ritonavir for oral treatment of Covid-19 Z Cao, W Gao, H Bao, H Feng, S Mei, P Chen, Y Gao, Z Cui, Q Zhang, ... New England Journal of Medicine 388 (5), 406-417, 2023 | 177 | 2023 |
| Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection Z Cao, Z Li, H Wang, Y Liu, Y Xu, R Mo, P Ren, L Chen, J Lu, H Li, ... Liver International 37 (11), 1612-1621, 2017 | 58 | 2017 |
| Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury R Mo, R Lai, J Lu, Y Zhuang, T Zhou, S Jiang, P Ren, Z Li, Z Cao, Y Liu, ... Theranostics 8 (15), 4170, 2018 | 57 | 2018 |
| The use of NACSELD and EASL-CLIF classification systems of ACLF in the prediction of prognosis in hospitalized patients with cirrhosis Z Cao, Y Liu, M Cai, Y Xu, X Xiang, G Zhao, W Cai, H Wang, W Wang, ... Official journal of the American College of Gastroenterology| ACG 115 (12 …, 2020 | 56 | 2020 |
| Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study Y Xu, Y Liu, Z Cao, L Wang, Z Li, Z Sheng, W Cai, H Wang, S Bao, Q Xie Digestive and Liver Disease 51 (9), 1323-1329, 2019 | 43 | 2019 |
| Interferon-based treatment is superior to nucleos (t) ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk P Ren, Z Cao, R Mo, Y Liu, L Chen, Z Li, T Zhou, J Lu, Y Liu, Q Guo, ... Expert Opinion on Biological Therapy 18 (10), 1085-1094, 2018 | 41 | 2018 |
| Circulating cell death biomarker: good candidates of prognostic indicator for patients with hepatitis B virus related acute-on-chronic liver failure Z Cao, F Li, X Xiang, K Liu, Y Liu, W Tang, L Lin, Q Guo, S Bao, Q Xie, ... Scientific Reports 5 (1), 14240, 2015 | 41 | 2015 |
| Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma Y Ding, K Liu, Y Xu, Q Zhao, S Lou, X Xiang, L Yan, Z Cao, Q Xie, C Zhu, ... Cancer Medicine 9 (9), 3057-3069, 2020 | 37 | 2020 |
| Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection Z Cao, Z Li, Y Wang, Y Liu, R Mo, P Ren, L Chen, J Lu, H Li, Y Zhuang, ... Journal of Viral Hepatitis 24, 57-65, 2017 | 35 | 2017 |
| Exacerbation of autoimmune hepatitis after COVID‐19 vaccination Z Cao, H Gui, Z Sheng, H Xin, Q Xie Hepatology 75 (3), 757-759, 2022 | 31 | 2022 |
| The impact of HBV flare on the outcome of HBV‐related decompensated cirrhosis patients with bacterial infection Z Cao, Y Liu, S Wang, X Lu, S Yin, S Jiang, L Chen, M Cai, B Zeng, Y Yao, ... Liver International 39 (10), 1943-1953, 2019 | 30 | 2019 |
| A high percentage of patients recovered from COVID-19 but discharged with abnormal liver function tests Q Gan, B Gong, M Sun, Z Cao, Y Zheng, Y Zhang, P Wen, Y Shen, L Hong, ... Frontiers in physiology 12, 642922, 2021 | 24 | 2021 |
| Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinoma P Wang, R Mo, R Lai, Y Xu, J Lu, G Zhao, Y Liu, Z Cao, X Wang, Z Li, ... Oncotarget 8 (62), 105407, 2017 | 24 | 2017 |
| COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status Z Cao, C Zhang, S Zhao, Z Sheng, X Xiang, R Li, Z Qian, Y Wang, B Chen, ... Infectious diseases of poverty 11 (1), 56, 2022 | 21 | 2022 |
| Application of fatty liver inhibition of progression algorithm and steatosis, activity, and fibrosis score to assess the impact of non-alcoholic fatty liver on untreated … Y Huang, Q Gan, R Lai, W Wang, S Guo, Z Sheng, L Chen, Q Guo, W Cai, ... Frontiers in Cellular and Infection Microbiology 11, 733348, 2022 | 21 | 2022 |
| Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study ZJ Cao, YH Liu, CW Zhu, S Yin, WJ Wang, WL Tang, GD Zhao, YM Xu, ... World journal of gastroenterology 26 (6), 645, 2020 | 20 | 2020 |
| SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease Y Liu, F Yu, Y Han, Q Li, Z Cao, X Xiang, S Jiang, X Wang, J Lu, R Lai, ... Scientific reports 6 (1), 37351, 2016 | 20 | 2016 |
| Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage J Jia, L Yang, Z Cao, M Wang, Y Ma, X Ma, Q Liu, J Teng, H Shi, H Liu, ... Rheumatology 60 (1), 304-315, 2021 | 19 | 2021 |